• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat. Commun. Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infection

tetano

Editor, Senior Moderator
Nat Commun. 2019 Jul 31;10(1):3422. doi: 10.1038/s41467-019-11249-y.
[h=1]Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infection.[/h] Tang BM[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Shojaei M[SUP]4,[/SUP][SUP]5[/SUP], Teoh S[SUP]4[/SUP], Meyers A[SUP]6[/SUP], Ho J[SUP]6[/SUP], Ball TB[SUP]6[/SUP], Keynan Y[SUP]7[/SUP], Pisipati A[SUP]8[/SUP], Kumar A[SUP]9[/SUP], Eisen DP[SUP]10[/SUP], Lai K[SUP]11[/SUP], Gillett M[SUP]12[/SUP], Santram R[SUP]13[/SUP], Geffers R[SUP]14[/SUP], Schreiber J[SUP]15[/SUP], Mozhui K[SUP]16[/SUP], Huang S[SUP]4[/SUP], Parnell GP[SUP]5[/SUP], Nalos M[SUP]4,[/SUP][SUP]17[/SUP], Holubova M[SUP]18[/SUP], Chew T[SUP]19[/SUP], Booth D[SUP]5[/SUP], Kumar A[SUP]20[/SUP], McLean A[SUP]4[/SUP], Schughart K[SUP]21,[/SUP][SUP]22,[/SUP][SUP]23[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Severe influenza infection has no effective treatment available. One of the key barriers to developing host-directed therapy is a lack of reliable prognostic factors needed to guide such therapy. Here, we use a network analysis approach to identify host factors associated with severe influenza and fatal outcome. In influenza patients with moderate-to-severe diseases, we uncover a complex landscape of immunological pathways, with the main changes occurring in pathways related to circulating neutrophils. Patients with severe disease display excessive neutrophil extracellular traps formation, neutrophil-inflammation and delayed apoptosis, all of which have been associated with fatal outcome in animal models. Excessive neutrophil activation correlates with worsening oxygenation impairment and predicted fatal outcome (AUROC 0.817-0.898). These findings provide new evidence that neutrophil-dominated host response is associated with poor outcomes. Measuring neutrophil-related changes may improve risk stratification and patient selection, a critical first step in developing host-directed immune therapy.


PMID: 31366921 DOI: 10.1038/s41467-019-11249-y
 
Back
Top Bottom